Compare Abeona Therapeutics Inc (ABEO) vs iShares Bitcoin Trust (IBIT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs iShares Bitcoin Trust — how do they compare? Abeona Therapeutics Inc trades at $6.71 (market cap $373.32M), while iShares Bitcoin Trust trades at $35.12. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, iShares Bitcoin Trust nearer its low. Which is the better fit depends on your goals.
| ABEO | IBIT | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Crypto-linked |
52-Week High | $7.23 | $71.29 |
52-Week Low | $4.17 | $33.29 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
IBIT trades at $36.12, up 3.58% today, with a bullish technical signal despite bearish moving averages. Key support lies at $35 and resistance at $37. The stock faces headwinds from sector volatility and significant ETF outflows, as reported by Zacks Investment Research on 2026-07-06. Recent news highlights competitive pressures among Bitcoin ETFs, with IBIT leading in assets under management according to The Motley Fool on 2026-06-29.
The outlook remains cautious due to market sentiment shifts and regulatory uncertainties. Investment opportunities hinge on the company's ability to maintain its asset scale advantage, while risks include continued investor outflows and broader crypto market declines impacting related equities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About iShares Bitcoin Trust
IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.
Read more on IBIT →
